Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Kobe J Med Sci. 2021 Jun 18;67(1):E10-E17.
The prognosis of hepatocellular carcinoma (HCC) presenting with inferior vena cava tumor thrombus (IVCTT) is extremely poor. The aim of this study was to reveal the postoperative course and to identify patients who have survived surgical hepatectomy among HCC patients with IVCTT. Between January 2006 and December 2018, 643 patients underwent surgical hepatectomy for HCC at Kobe University Hospital. Among them, 20 patients were categorized as Vv3 according to the Japanese staging system. We retrospectively collected detailed data on these patients. The statistical, clinical, and pathological data were recorded prospectively and analyzed retrospectively. The median survival time was 9.8 months. Among all patients, 11 (55%) achieved R0 resection, and only two survivors were from this group. The number of tumors (solitary vs. multiple; p=0.050) and pathological Vp (pVp0 vs. other; p=0.009) were identified as risk factors for overall survival in the univariate analysis. In the multivariate analysis, pathological Vp (pVp0 vs. other; p=0.037) was identified as a significant prognostic factor for survival. Pathological Vp affected overall survival among IVCTT patients; the median survival time was 53.7 months with pVp0, 10.2 months with pVp1, and 8.8 months with pVp2-4 (p=0.035). For patients with IVCTT, surgical hepatectomy should be indicated only for those who do not have portal vein invasion and could achieve R0 resection.
肝细胞癌(HCC)伴下腔静脉癌栓(IVCTT)的预后极差。本研究旨在揭示术后过程,并确定 HCC 伴 IVCTT 患者中接受手术肝切除后存活的患者。2006 年 1 月至 2018 年 12 月,神户大学医院共有 643 例 HCC 患者接受手术肝切除。其中,20 例患者根据日本分期系统分为 Vv3 期。我们回顾性收集了这些患者的详细资料。统计、临床和病理数据前瞻性收集并回顾性分析。中位生存时间为 9.8 个月。所有患者中,11 例(55%)达到 R0 切除,只有 2 例存活者来自该组。肿瘤数量(单发与多发;p=0.050)和病理 Vp(pVp0 与其他;p=0.009)在单因素分析中被确定为总生存的危险因素。在多因素分析中,病理 Vp(pVp0 与其他;p=0.037)被确定为生存的显著预后因素。病理 Vp 影响 IVCTT 患者的总生存;pVp0 的中位生存时间为 53.7 个月,pVp1 为 10.2 个月,pVp2-4 为 8.8 个月(p=0.035)。对于 IVCTT 患者,只有无门静脉侵犯且能达到 R0 切除的患者才应行手术肝切除。